NCT06995742 Effect of ANNE One-Wellue Device Array Use on Staff Bedside Vital Sign Measurement Activity
| NCT ID | NCT06995742 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Northwestern University |
| Condition | Vital Sign Evaluation |
| Study Type | INTERVENTIONAL |
| Enrollment | 270 participants |
| Start Date | 2025-06-02 |
| Primary Completion | 2026-07-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 270 participants in total. It began in 2025-06-02 with a primary completion date of 2026-07-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Randomized controlled trial of a time motion study of time spent obtaining and charting vital signs for inpatients, comparing use of a wireless Bluetooth vital sign array as intervention versus routine vital sign obtainment activity on a general medical floor.
Eligibility Criteria
Inclusion Criteria: * Inpatients admitted to Northwestern Memorial Hospital, Feinberg Unit 16 West. Exclusion Criteria: * Primary language other than English, under isolation status, pregnant patients, prisoners, employees or students of the hospital or Northwestern University.
Contact & Investigator
Gregory (Randy) R Smith Jr, MD MS
PRINCIPAL INVESTIGATOR
Northwestern University
Frequently Asked Questions
Who can join the NCT06995742 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Vital Sign Evaluation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06995742 currently recruiting?
Yes, NCT06995742 is actively recruiting participants. Contact the research team at g.smith@nm.org for enrollment information.
Where is the NCT06995742 trial being conducted?
This trial is being conducted at Chicago, United States, Chicago, United States.
Who is sponsoring the NCT06995742 clinical trial?
NCT06995742 is sponsored by Northwestern University. The principal investigator is Gregory (Randy) R Smith Jr, MD MS at Northwestern University. The trial plans to enroll 270 participants.